>The clinical trials follow peer-reviewed research conducted at the
University of Southampton in the U.K. proving copper, brass and bronze can
quickly and efficiently eradicate several different pathogens which are the
source of many hospital-acquired infections. Estimates from the U.S.
Centers for Disease Control and Prevention (CDC) state that infections
acquired in U.S. hospitals affect some two million individuals every year,
resulting in nearly 100,000 deaths annually and costing the healthcare
industry some $30 billion. It is widely believed those numbers will grow,
unless more effective measures are implemented.
The touch surfaces trials will determine how well natural copper, brass
and bronze surfaces mitigate infectious microbes, decrease
cross-contamination and ultimately help reduce the incidence of
hospital-acquired infections in patients. Rates of infection are being
measured using three indicator organisms: MRSA, vancomycin-resistant
Enterococci (VRE) and Acinetobacter baumannii. The surfaces involved in the
study are typically made of coated carbon steel, aluminum, stainless steel
or plastic, which have little or no effect in controlling pathogens.
The studies are being conducted at Memorial Sloan-Kettering Cancer
Center in New York City, the Medical University of South Carolina and the
Ralph H. Johnson VA Medial Center, both in Charleston, South Carolina.
Previous studies were conducted by ATS Labs in Eagan, Minnesota, under test
protocols established by the U.S. Environmental Protection Agency. They
show solid copper alloys are more than 99.9% effective on five pathogens
commonly found in healthcare facilities. The tests have been submitted to
EPA as part of a registration process to secure approval for making human
health claims for the copper metals.
The companion study compares copper air-conditioning system components,
including heat exchangers and drip pans, with components made of aluminum
as to their ability to control the g
'/>"/>
SOURCE Copper Development Association Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine technology :1.
Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health2.
Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals3.
Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors4.
Nobel Prize Awarded to Foundation for Biomedical Research Board Member5.
National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD6.
SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases7.
California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation8.
Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease9.
Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor10.
deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack11.
Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing